Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H22FN3 |
| Molecular Weight | 359.4393 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C2=C(C(=CN2)C3=C[C@@H]4CCCN4CC3)C5=CC=NC=C5
InChI
InChIKey=KVBWUPVGVUIAIX-FQEVSTJZSA-N
InChI=1S/C23H22FN3/c24-19-5-3-17(4-6-19)23-22(16-7-10-25-11-8-16)21(15-26-23)18-9-13-27-12-1-2-20(27)14-18/h3-8,10-11,14-15,20,26H,1-2,9,12-13H2/t20-/m0/s1
| Molecular Formula | C23H22FN3 |
| Molecular Weight | 359.4393 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 17:41:27 GMT 2025
by
admin
on
Tue Apr 01 17:41:27 GMT 2025
|
| Record UNII |
4V9C6FBZ7M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
321344-57-4
Created by
admin on Tue Apr 01 17:41:27 GMT 2025 , Edited by admin on Tue Apr 01 17:41:27 GMT 2025
|
PRIMARY | |||
|
4V9C6FBZ7M
Created by
admin on Tue Apr 01 17:41:27 GMT 2025 , Edited by admin on Tue Apr 01 17:41:27 GMT 2025
|
PRIMARY | |||
|
9811100
Created by
admin on Tue Apr 01 17:41:27 GMT 2025 , Edited by admin on Tue Apr 01 17:41:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Compound 4a, (S)-2-(4-fluorophenyl)-4-(1,2,3,5,6,8a-hexahydroindolizin-7-yl)-3-(pyridin-4-yl)-1H-pyrrole (R-132811), achieved the most promising results in various in vitro and in vivo tests including several rheumatoid arthritis models.
|
